![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Ra Medical Systems Achieves FDA Clearance For Peripheral Artery Disease Treatment
Ra Medical Systems Achieves FDA Clearance For Peripheral Artery Disease Treatment
![Heart Yellow Small](https://www.fdanews.com/ext/resources/test/Device_Images/HeartYellow_Small.gif?height=150&t=1433878519)
The FDA has granted marketing clearance to Ra Medical Systems for its DABRA System for peripheral artery disease treatment.
The device is a catheter and excimer laser system for the treatment of complex and diffuse arterial blockages in the lower vessels.
The single-use catheter produces a lumen while minimizing trauma to the vasculature. It is a full catheter tip forward cutter, without the “dead-space” of fiber optic bundle catheters.
The DABRA laser photochemically ablates arterial blockages, reducing calcium, thrombus and atheroma, minimizing downstream debris. The portable laser weighs about 100 pounds. — Cynthia Jessup
Upcoming Events
-
21Oct